Trial intelligence / Profile preview

Oral minoxidil for androgenetic alopecia

IRCT20221101056366N1Phase 3Completed

Sponsor
Tehran University of Medical Sciences
Start
Feb 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of minoxidil in androgenetic alopecia (AGA), sponsored by Tehran University of Medical Sciences. Started Feb 2023; status: completed.

02

Drugs

minoxidil
03

Conditions

androgenetic alopecia (AGA)

Beyond the preview

Go deeper on IRCT20221101056366N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20221101056366N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call